Noise level: Our pick for the best quiet CPAP machine is the Luna G3, but you'll want to make sure that whichever model you ...

ResMed dominates healthcare devices with innovation, recurring revenues, and market leadership. See why we believe RMD stock ...

Resmed beat Wall Street estimates for third-quarter profit on Wednesday, driven by demand for its sleep apnea devices used to manage the common sleep disorder.

or CPAP, with another 34 million remaining undiagnosed. ResMed operates in over 140 countries with over 900 million people estimated to have sleep apnea globally, indicating the long runway for ...

Free Cash Flow: Strong generation reported. ResMed Inc (NYSE:RMD) reported strong financial performance with an 8% increase in group revenue, reaching $1.29 billion for Q3 fiscal year 2025.

Discover ResMed's Q3 2025 earnings highlights, including 8% revenue growth, margin expansion, new product launches, and strategic investments in ...

KeyBanc analyst Brett Fishbin raised the firm’s price target on ResMed (RMD) to $274 from $269 on higher estimates, while keeping an Overweight ...

Picture: Al Drago for The Washington Post via Getty Images ResMed's CPAP machines, which are used by those suffering with sleep apnea, will be exempt from Trump's tariffs. Picture: Getty Images ...

Analyst Margaret Kaczor Andrew writes, “This is welcome news, with ResMed the first company this earnings cycle in our coverage universe to report as much.” Analyst Reaction: Keybanc maintains ...

In a report released today, Adam Maeder from Piper Sandler maintained a Hold rating on Resmed (RMD – Research Report), with a price target of $248.00. The company’s shares closed yesterday at ...